Vaginal Candidiasis A Treatment
Mostrando 1-12 de 30 artigos, teses e dissertações.
-
1. Geopropolis gel for the adjuvant treatment of candidiasis – formulation and in vitro release assay
ABSTRACT The geopropolis produced by the stingless bee Melipona subnitida (popularly called "jandaíra" in Brazil) is a mixture of resin, wax, and mud. This study analyzed the antifungal activity of the geopropolis extract from Candida spp., developed a gel formulation with this extract and analyzed the delivery of bioactives (kinetics release) in the formul
Rev. bras. farmacogn.. Publicado em: 26/08/2019
-
2. In vitro antifungal activity of Myracrodruon urundeuva Allemão against human vaginal Candida species
ABSTRACT Myracrodruon urundeuva is a plant native to Brazil, which is used by the indigenous population for the treatment of candidiasis. The aims of this study were to evaluate the antifungal activity of extract against human vaginal Candida species and evaluate the possible toxicological activities of M. urundeuva. Initially, ethanol extracts, ethyl acetat
An. Acad. Bras. Ciênc.. Publicado em: 24/07/2017
-
3. Chronic mucocutaneous candidiasis: a case with exuberant cutaneous horns in nipples
Chronic mucocutaneous candidiasis is a rare disorder characterized by persistent and recurrent infections by Candida due to changes in cellular immunity and may be associated with autoimmune endocrine disorders. It is refractory to the usual antifungal treatments, which merely control it with imidazole derivatives. This reports the case of a 50-year-old fema
An. Bras. Dermatol.. Publicado em: 2014-07
-
4. In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
A maioria das novas entidades químicas e muitas moléculas de fármacos existentes apresenta fraca solubilidade em água, o que pode limitar seu uso potencial no desenvolvimento de formulações com biodisponibilidade ideal. Uma das abordagens para melhorar a solubilidade de um fármaco pouco solúvel em água e, eventualmente, a sua biodisponibilidade é a
Braz. J. Pharm. Sci.. Publicado em: 2012-12
-
5. In vitro activity of Origanum vulgare essential oil against Candida species
The aim of this study was to evaluate the in vitro activity of the essential oil extracted from Origanum vulgare against sixteen Candida species isolates. Standard strains tested comprised C. albicans (ATCC strains 44858, 4053, 18804 and 3691), C. parapsilosis (ATCC 22019), C. krusei (ATCC 34135), C. lusitaniae (ATCC 34449) and C. dubliniensis (ATCC MY646).
Brazilian Journal of Microbiology. Publicado em: 2010-03
-
6. In vitro activity of Origanum vulgare essential oil against Candida species
The aim of this study was to evaluate the in vitro activity of the essential oil extracted from Origanum vulgare against sixteen Candida species isolates. Standard strains tested comprised C. albicans (ATCC strains 44858, 4053, 18804 and 3691), C. parapsilosis (ATCC 22019), C. krusei (ATCC 34135), C. lusitaniae (ATCC 34449) and C. dubliniensis (ATCC MY646).
Publicado em: 2010
-
7. Therapeutic study of gomesina in mice with disseminated and vaginal candidiasis. / Estudo terapêutico da gomesina em camundongos com candidíase disseminada e vaginal.
A gomesina é um peptídeo antimicrobiano catiônico, purificado dos hemócitos da aranha caranguejeira Acanthoscurria gomesiana. Possui amplo espectro de atividade contra bactérias, fungos, protozoários e células tumorais. Candida albicans é uma levedura comensal que faz parte da microbiota humana. O tratamento desta micose geralmente é feito com fluco
Publicado em: 2009
-
8. Accuracy of a self-collection kit for the microbiological study of the vaginal content
Diagnosis of vaginal discharge is frequently performed in an empirical way, leading to inadequate treatment. This study tested the accuracy of a self-collection kit for microbiological study of the vaginal content. One hundred and forty-two women of Family Health Program units in Niterói and Piraí cities were enrolled in order to have their vaginal content
Brazilian Journal of Infectious Diseases. Publicado em: 2007-04
-
9. Avaliação da eficácia e tolerabilidade do uso de óvulos vaginais contendo metronidazol e nitrato de miconazol no tratamento de vaginites
Infections of the lower female genital tract are one of the principal reasons for women to seek gynecological care. Throughout their lifetime, 75% of women will have at least one episode of this affliction. A projection for Brazil estimates that the costs resulting from vaginitis are close to 80 million dollars annually. Bacterial vaginosis, candidiasis and
Publicado em: 2007
-
10. AvaliaÃÃo da atividade antifÃngica de Lippia sidoides cham. (verbenaceae) para obtenÃÃo de um creme de aplicaÃÃo vagina / Evaluation of the antifungical activity of Lippia sidoides cham. (verbenaceae) for obtaining of a cream of vaginal application
No Brasil, o uso popular de plantas com propriedades curativas à uma prÃtica secular deixada como heranÃa pelos Ãndios, negros e europeus e largamente utilizada na RegiÃo Nordeste. Lippia sidoides Cham. (Verbenaceae), freqÃente na caatinga nordestina, à utilizada no tratamento de infecÃÃes da cavidade oral e da vagina, por apresentar forte atividade
Publicado em: 2006
-
11. Miconazole nitrate compared with chlordantoin in the treatment of vaginal candidiasis.
In a double-blind study of the treatment of vaginal candidiasis, miconazole nitrate gave a cure-rate of 88 per cent. (29 out of 33) compared with 58 per cent. (21 out of 36) using chlordantoin. Although approximately two-thirds of the patients who responded did so to a 10-day course of treatment, the different rates of cure with these preparations at this st
-
12. Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet.
The therapeutic efficacy of intermittent, monthly, postmenstrual prophylaxis with a single 500 mg clotrimazole vaginal tablet (n = 33) was compared with placebo tablets (n = 29) in 62 woman (age 28.1, SD 7.2 years) with recurrent vulvovaginal candidiasis. The number of episodes of acute vulvovaginal candidiasis experienced during the year prior to inclusion